コンテンツにスキップ

Amiloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects, An Issue of Heart Failure Clinics, E-Book, 1st Edition

著者 :
Edited by Giuseppe Limongelli, MD, PhD, FESC, Michele Emdin, MD, PhD, FESC, FHFA, Marco Merlo, MD, PhD and Emanuele Monda, MD, PhD
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects ...view more
In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.
ISBNコード :
9780443121449
出版日 :
07-06-2024
カートに入れる

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

!消費税はご注文決済前に表示・適用されます!

In this issue of Heart Failure Clinics, guest editors Drs. Giuseppe Limongelli, Michele Emdin, Marco Merlo, and Claudio Rapezzi bring their considerable expertise to the topic of Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects. Top experts in the field discuss the role of clinical use of biomarkers in cardiac amyloidosis; cardiac magnetic resonance in the management of cardiac amyloidosis; bone scintigraphy: strength points and pitfalls in the diagnosis of ATTR-cardiac amyloidosis; PET and cardiac amyloidosis; endomyocardial biopsy in the diagnosis of cardiac amyloidosis; and much more.

特長
  • Contains 17 relevant, practice-oriented topics including the changing epidemiology of cardiac amyloidosis; arrhythmic stratification of cardiac amyloidosis: state of the art; specific therapy in ATTR-related cardiomyopathy: future perspectives beyond tafamidis; and more.
  • Provides in-depth clinical reviews on amyloid cardiomyopathies, offering actionable insights for clinical practice.
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

著者情報
Edited by Giuseppe Limongelli, MD, PhD, FESC, Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Naples, Italy; Michele Emdin, MD, PhD, FESC, FHFA, Full Professor of Cardiovascular Diseases Health Science Interdisciplinary Center, Coordinator Scuola Superiore Sant'Anna - Sant'Anna School of Advanced Studies Piazza Martiri della Libert, Pisa, Italy; Marco Merlo, MD, PhD, Department of Energy, Politecnico di Milano, Milano, Italy and Emanuele Monda, MD, PhD, Inherited and Rare Cardiovascular Disease Clinic, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
詳細情報
ISBN Number 9780443121449
Description Author List Edited by Giuseppe Limongelli, MD, PhD, FESC, Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Naples, Italy; Michele Emdin, MD, PhD, FESC, FHFA, Full Professor of Cardiovascular Diseases Health Science Interdisciplinary Center, Coordinator Scuola Superiore Sant'Anna - Sant'Anna School of Advanced Studies Piazza Martiri della Libert, Pisa, Italy; Marco Merlo, MD, PhD, Department of Energy, Politecnico di Milano, Milano, Italy and Emanuele Monda, MD, PhD, Inherited and Rare Cardiovascular Disease Clinic, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
Copyright Year 2024
Edition Number 1
Format E-Book
Trim 178w x 254h (7.00" x 10.00")
Imprint Elsevier
Page Count 240
Publication Date 7 Jun 2024
Stock Status IN STOCK
Amyloidosis and Amyloidogenesis: One Name, Many Diseases
Pathophysiology of Cardiac Amyloidosis
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis
Clinical Use of Biomarkers in Cardiac Amyloidosis
Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update
Standard Therapy in Cardiac Amyloidosis: What is Known, What is “Gray”
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey Zones
Specific Therapy in Transthyretin Amyloid Cardiomyopathy: Future Perspectives Beyond Tafamidis
あなたのレビューを投稿する
登録ユーザーのみがレビューを書くことができます。 ログインするか、アカウントを作成してください